バイオバンキング市場 – 2030年までの世界予測

バイオバンキング市場は2025年の76億5,000万米ドルから2030年には118億2,000万米ドルに達し、予測期間中に9.1%の年平均成長率（CAGR）で成長すると予測されています。精密医療への関心の高まりと、細胞・遺伝子治療のパイプラインの拡大は、バイオバンキング市場の成長を大きく後押しすると見込まれます。個々の遺伝子プロファイルに合わせて治療を行う精密医療は、個別化治療の基盤となる高品質で保存状態の良い生体サンプルへの需要をますます高めています。さらに、細胞・遺伝子治療のパイプラインの拡大は、今後数年間、バイオバンキング市場の主要な牽引役となることが予想されます。幹細胞、遺伝子編集、その他の高度なバイオテクノロジーを基盤とする新たな細胞・遺伝子治療の開発には、膨大な量の生体材料の保管と管理が必要です。バイオバンクは、サンプルの保管、処理、配布のための信頼性の高い標準化されたプラットフォームを提供することで、これらの治療を支える上で不可欠です。

MarketsandMarkets（マーケッツアンドマーケッツ）「バイオバンキング市場 – 製品（機器、消耗品、ソフトウェア）、サービス（仮想）、運用（自動化）、ワークフロー（保管、収集、輸送）、サンプル（血液、細胞株、核酸）、用途、所有権、エンドユーザー – 2030年までの世界予測 – Biobanking Market by Product (Equipment, Consumables, Software), Services (Virtual), Operation (Automated), Workflow (Storage, Collection, Transport), Sample (Blood, Cell Lines, Nucleic Acids), Application, Ownership, End User – Global Forecast to 2030」はバイオバンクの世界市場を調査し、主要セグメント別に分析・予測を行っています。

この調査レポートでは、バイオバンキング市場を提供内容（製品（機器、消耗品）、サービス（物理的バイオバンキング、仮想バイオバンキング、その他のサービス）、ソフトウェア）; ワークフロー（サンプルの収集と保管、サンプルの処理、サンプルの分析、輸送と物流）、操作タイプ（手動、自動）、サンプルタイプ（血液製剤、固形組織と臓器、幹細胞と細胞株、核酸、体液、ヒト排泄物）、エンドユーザー製品（バイオバンク、CRO）、エンドユーザーサービス（製薬、バイオテクノロジーおよびCRO、学術研究機関）、および地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）別に分類しています。レポートの範囲は、バイオバンキング市場の成長に影響を与える推進要因、制約、課題、機会などの主要要因に関する詳細情報を網羅しています。主要な業界プレーヤーを徹底的に分析することで、事業概要、サービス、製品、ソリューション、主要戦略、コラボレーション、パートナーシップ、契約に関する洞察が得られています。バイオバンキング市場に関連する最近の動向としては、新規製品の発売、コラボレーション、買収などが挙げられます。

本レポートは、バイオバンキング市場全体とそのサブセグメントの収益数値を最も近似値で示すことで、市場リーダー／新規参入企業を支援します。また、ステークホルダーが競争環境をより深く理解し、自社のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、機会、課題に関する情報を提供することを可能にします。

Report Overview

The biobanking market is projected to reach USD 11.82 billion by 2030 from USD 7.65 billion in 2025, at a CAGR of 9.1% during the forecast period. The growing focus on precision medicine and the expanding pipeline for cell and gene therapies are set to significantly fuel the growth of the biobanking market. Precision medicine, which tailors treatments to individual genetic profiles, is increasingly driving the need for high-quality, well-preserved biological samples, as these form the foundation for personalized therapies. Additionally, the growing pipeline for cell and gene therapies is expected to be a major driver for the biobanking market in the coming years. The development of new cell and gene therapies, which often rely on stem cells, gene editing, and other advanced biotechnologies, necessitates storing and managing vast amounts of biological material. Biobanks are essential in supporting these therapies by providing a reliable and standardized platform for sample storage, processing, and distribution.

The physical biobanking segment accounted for the largest share of the biobanking services market in 2024.

Based on services, the biobanking market is segmented into physical biobanking, virtual biobanking, and other services. In 2024, the large share of physical biobanking services in the market can be attributed to the essential role they play in sample collection, storage, and preservation under controlled conditions. Physical biobanks offer the infrastructure necessary to store a wide range of biological samples, including blood, tissues, and DNA, in environments such as freezers, cryogenic tanks, and refrigerators, ensuring sample integrity for long-term use. As the demand for high-quality biological specimens grows, driven by advancements in precision medicine and genomics, physical biobanks are crucial for maintaining the stability and accessibility of these samples. Additionally, the ability to provide reliable, on-site sample management and real-time monitoring systems has further cemented the importance of physical biobanks in supporting pharmaceutical, biotechnology, and research sectors.

By ownership, the private/commercial providers segment accounted for the largest share of the market in 2024.

Based on the ownership model, the biobanking services market is segmented into private/commercial providers, academic & research institutional biobanks, national/regional agencies, hybrid/PPP (public-private-partnership) models, and other ownership models. In 2024, the private/commercial providers segment accounted for the largest share of the global biobanking market. The large share of the private/commercial providers model in the biobanking market is primarily driven by the growing demand for high-quality, scalable, and commercially viable biobanking solutions. These providers can offer advanced, state-of-the-art infrastructure and technology for sample storage, processing, and distribution, often tailored to meet the specific needs of pharmaceutical, biotechnology, and clinical research sectors. Commercial providers are also more agile in adopting innovations and expanding their services to meet the evolving demands of precision medicine, genomic research, and clinical trials. Their ability to provide comprehensive, end-to-end biobanking services and focus on efficiency and regulatory compliance has made them essential partners for organizations seeking reliable and standardized biological sample management. As a result, the private/commercial ownership model continues to dominate the market, with private players capturing a significant share.

The US dominated the biobanking market in 2024.

In 2024, the US held a significant share of the North American biobanking market, driven by its advanced healthcare infrastructure, substantial investment in research and development, and leading role in precision medicine. With numerous world-renowned academic institutions, pharmaceutical companies, and research organizations, the US is at the forefront of generating and utilizing biological samples for a wide range of scientific advancements. The growing emphasis on personalized medicine, genomics, and clinical trials has increased the demand for high-quality biobanks in the region. Additionally, favorable regulatory frameworks and substantial public and private funding continue to support the expansion of biobanking services, solidifying the dominant position of the US in the market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply-side- 70% and Demand-side 30%
• By Designation: Managers – 45%, CXOs & Directors – 30%, and Executives – 25%
• By Region: North America – 40%, Europe -25%, Asia Pacific -25%, Latin America -5% and the Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• PHC Holdings Corporation (Japan)
• Becton, Dickinson and Company (BD) (US)
• Qiagen (Germany)
• Merck KGaA (Germany)
• Labcorp (US)
• Eurofins Scientific (Luxembourg)
• Cryoport (US)
• ICON Plc (Ireland)
• Tecan Trading AG (Switzerland)
• Azenta US Inc. (US)
• Avantor, Inc. (US)
• Greiner AG (Austria)
• Amsbio (UK)
• Labcorp (US)
• Eurofins Scientific (Luxembourg)
• Hamilton Company (US)
• BioIVT LLC (US)
• BioKryo (Germany)
• ASKION GmbH (Germany)
• Sopachem (Belgium)
• Froilabo (UK)
• Cureline (US)
• SPT Labtech Ltd (UK)

Research Coverage

This research report categorizes the biobanking market by offerings [products (equipment, consumables), services (physical biobanking, virtual biobanking, other services), software];  workflow (sample collection & storage, sample processing, sample analysis, transport & logistics), operation type (manual, automated), sample type (blood products, solid tissues & organs, stem cell & cell lines, nucleic acids, biological fluids, human waste products), end user- product (biobanks, CROs), end -user services (pharma, biotech & CROs, academic & research institutes), and region (North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa). The report’s scope covers detailed information regarding the leading factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the biobanking market. A thorough analysis of the key industry players has provided insights into their business overview, services, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are the recent developments associated with the biobanking market.

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall biobanking market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (growing focus on precision medicine & population-genomics programmes, cell- & gene-therapy pipeline expansion, adoption of energy-efficient Ultra Low Temperature(ULT) freezers, end-to-end automation & robotics for physical sample handling and storage), restraints (high upfront capital expenditure, sample quality variability), opportunities ( outsourcing of cryogenic storage to third-party specialists, growing focus on sustainability and green-lab solutions), and challenges (long-term funding stability for public biobanks) influencing the growth of the market.
• Product/Service Development/Innovation: Detailed insights on newly launched products, services of the biobanking market
• Market Development: Comprehensive information about lucrative markets – the report analyzes the market across varied regions.
• Market Diversification: Exhaustive information about new products, services, untapped geographies, recent developments, and investments in the biobanking market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of key players including Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (BD) (US), Qiagen (Germany), Labcorp (US), Eurofins Scientific (Luxembourg), Cryoport (US). A detailed analysis of the key industry players has been conducted to provide insights into their key strategies, product launches, acquisitions, partnerships, agreements, collaborations, expansions, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the biobanking product and service market.

Table of Contents

1               INTRODUCTION              46

1.1           STUDY OBJECTIVES       46

1.2           MARKET DEFINITION   46

1.3           STUDY SCOPE   46

1.3.1        BIOBANKING MARKET SEGMENTATION & REGIONAL SCOPE  47

1.3.2        INCLUSIONS & EXCLUSIONS       48

1.3.3        YEARS CONSIDERED      49

1.3.4        CURRENCY CONSIDERED            50

1.4           STAKEHOLDERS               50

1.5           SUMMARY OF CHANGES               50

2               RESEARCH METHODOLOGY       52

2.1           RESEARCH DATA              52

2.1.1        SECONDARY DATA          53

2.1.1.1    Key sources of secondary data            53

2.1.1.2    Key objectives of secondary research                 53

2.1.2        PRIMARY DATA 54

2.1.2.1    Breakdown of primaries      54

2.1.2.2    Key objectives of primary research    55

2.2           MARKET ESTIMATION METHODOLOGY               55

2.2.1        GLOBAL MARKET SIZE ESTIMATION, 2024            55

2.2.1.1    Company revenue analysis (bottom-up approach)         55

2.2.1.2    MnM repository analysis     57

2.2.1.3    Primary interviews                58

2.2.1.4    Insights from primary sources            58

2.2.2        SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)       58

2.3           MARKET GROWTH RATE FORECAST       60

2.3.1        IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS             61

2.3.2        BIOBANKING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS          62

2.4           DATA TRIANGULATION                62

2.5           STUDY ASSUMPTIONS  63

2.6           RESEARCH LIMITATIONS             64

2.7           RISK ANALYSIS  65

3               EXECUTIVE SUMMARY  66

3.1           KEY INSIGHTS & MARKET HIGHLIGHTS 66

3.2           STRATEGIC IMPERATIVES FOR STAKEHOLDERS                 70

3.2.1        BIOBANKING EQUIPMENT MANUFACTURERS   70

3.2.2        BIOBANKING CONSUMABLE MANUFACTURERS                 70

3.2.3        BIOBANKING SERVICE PROVIDERS          71

4               PREMIUM INSIGHTS       72

4.1           BIOBANKING MARKET OVERVIEW           72

4.2           NORTH AMERICA: BIOBANKING MARKET, BY OFFERING AND COUNTRY, 2024      73

4.3          BIOBANKING PRODUCTS MARKET SHARE, BY END USER, 2024        73

4.4           BIOBANKING SERVICES MARKET SHARE, BY END USER, 2024        74

4.5           BIOBANKING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              74

5               MARKET OVERVIEW       75

5.1           INTRODUCTION              75

5.2           MARKET DYNAMICS       75

5.2.1        DRIVERS               76

5.2.1.1    Growing focus on precision medicine & population genomics programs                76

5.2.1.2    Expansion of cell & gene therapy pipeline        77

5.2.1.3    Adoption of energy-efficient ULT freezers      77

5.2.1.4    Integration of end-to-end automation & robotics for sample handling & storage                78

5.2.2        RESTRAINTS      78

5.2.2.1    High capital expenditure     78

5.2.2.2    Variability associated with sample quality        79

5.2.3        OPPORTUNITIES              79

5.2.3.1    Outsourcing of activities by SME biopharma companies to third-party specialists    79

5.2.3.2    Increasing focus on sustainability & green-lab solutions                 80

5.2.4        CHALLENGES    80

5.2.4.1    Challenges associated with long-term funding stability for public biobanks 80

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       81

5.3.1        STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES                 81

5.4           PRICING ANALYSIS          82

5.4.1        AVERAGE SELLING PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER, 2024      82

5.4.2        INDICATIVE PRICING OF BIOBANKING SERVICES, BY SERVICE TYPE, 2024         83

5.4.3        INDICATIVE PRICING TREND FOR BIOBANKING MARKET, BY REGION, 2022−2024               83

5.5           VALUE CHAIN ANALYSIS               84

5.6           ECOSYSTEM ANALYSIS  85

5.6.1        ROLE IN ECOSYSTEM     86

5.6.2        EMERGING BUSINESS MODELS & ECOSYSTEM SHIFT IN BIOBANKING MARKET  88

5.7           PATENT ANALYSIS          88

5.8           LIST OF KEY PATENTS   90

5.9           TECHNOLOGY ANALYSIS             91

5.9.1        KEY TECHNOLOGIES     91

5.9.1.1    Automated sample collection and processing technologies                 91

5.9.1.2    Sample analysis technologies              91

5.9.2        COMPLEMENTARY TECHNOLOGIES       92

5.9.2.1    Data management & informatics       92

5.9.2.2    AI & ML in biobanking       92

5.10         KEY CONFERENCES & EVENTS, 2025−2026            93

5.11         REGULATORY ANALYSIS               93

5.11.1      REGULATORY FRAMEWORK       94

5.11.1.1  North America      94

5.11.1.2  Europe   94

5.11.1.3  Asia Pacific            94

5.11.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             95

5.12         TRADE ANALYSIS             96

5.12.1      IMPORT DATA FOR HS CODE 8418, 2020–2024      96

5.12.2      EXPORT DATA FOR HS CODE 8418, 2020–2024      97

5.13         PORTER’S FIVE FORCES ANALYSIS           97

5.13.1      THREAT OF NEW ENTRANTS      98

5.13.2      THREAT OF SUBSTITUTES          99

5.13.3      BARGAINING POWER OF BUYERS             99

5.13.4      BARGAINING POWER OF SUPPLIERS       99

5.13.5      INTENSITY OF COMPETITIVE RIVALRY 99

5.14         KEY STAKEHOLDERS & BUYING CRITERIA            100

5.14.1      KEY STAKEHOLDERS IN BUYING PROCESS           100

5.14.2      KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS, BY END USER     101

5.14.3      KEY BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER            102

5.14.4      UNMET NEEDS & WHITE SPACES              103

5.15         INVESTMENT & FUNDING SCENARIO     104

5.15.1      VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE, 2024             105

5.16         IMPACT OF AI/GEN AI ON BIOBANKING MARKET                 105

5.16.1      INTRODUCTION              105

5.16.2      USE CASES           105

5.16.3      FUTURE OF AI IN BIOBANKING MARKET ECOSYSTEM                 106

5.17         IMPACT OF 2025 US TARIFF ON BIOBANKING MARKET                 107

5.17.1      INTRODUCTION              107

5.17.2      KEY TARIFF RATES          107

5.17.3      PRICE IMPACT ANALYSIS             108

5.17.4      KEY IMPACTS ON COUNTRIES/REGIONS              108

5.17.4.1  North America      108

5.17.4.1.1                US           108

5.17.4.2  Europe   109

5.17.4.3  Asia Pacific            109

5.17.5      IMPACT ON END-USE INDUSTRIES          109

5.17.5.1  Biobanks                109

5.17.5.2  CROs      110

6               BIOBANKING MARKET, BY OFFERING    111

6.1           INTRODUCTION              112

6.2           PRODUCTS         113

6.2.1        EQUIPMENT      116

6.2.1.1    Freezers & refrigerators       118

6.2.1.1.1 Storage of blood, DNA, and serum to fuel market growth                 118

6.2.1.2    Cryogenic storage systems  121

6.2.1.2.1 Rising demand for cell & gene therapies to fuel market 121

6.2.1.3    Alarm & monitoring systems              124

6.2.1.3.1 Regulatory demand for continuous monitoring to support market growth    124

6.2.1.4    Thawing equipment             126

6.2.1.4.1 Growing demand for CAR-T and mRNA therapies to fuel uptake                 126

6.2.1.5    Temperature & humidity control systems        129

6.2.1.5.1 Critical role in maintaining sample integrity to aid adoption                 129

6.2.1.6    Other equipment & accessories         132

6.2.2        CONSUMABLES 134

6.2.2.1    Surging sample volumes and recurring demand to drive market                 134

6.3           SERVICES             137

6.3.1        OUTSOURCING OF SERVICES TO CROS TO DRIVE MARKET               137

6.4           SOFTWARE         140

6.4.1        GROWING FOCUS ON AUTOMATION TO PROPEL MARKET               140

7               BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY OPERATION TYPE            144

7.1           INTRODUCTION              145

7.2           MANUAL OPERATIONS 145

7.2.1        LARGE EXISTING INSTALLED BASE AND NO REQUIREMENT FOR SPECIALIZED LABOR TO DRIVE MARKET                 145

7.3           AUTOMATED OPERATIONS        148

7.3.1        INCREASING INNOVATION AND RISING TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET                 148

8               BIOBANKING PRODUCTS MARKET, BY WORKFLOW                 152

8.1           INTRODUCTION              153

8.2           SAMPLE COLLECTION & STORAGE          153

8.2.1        LARGE RESEARCH COHORTS AND SUSTAINABILITY MANDATES TO DRIVE MARKET 153

8.3           SAMPLE PROCESSING    156

8.3.1        AUTOMATION DEMAND AND COMPLIANCE RULES TO FUEL MARKET   156

8.4           SAMPLE ANALYSIS           159

8.4.1        HIGH DEMAND FOR ACTIONABLE DATA TO FUEL MARKET               159

8.5           TRANSPORT & LOGISTICS           162

8.5.1        TEMPERATURE-SENSITIVE REQUIREMENTS TO SUPPORT PRODUCTS UPTAKE  162

9               BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE                 166

9.1           INTRODUCTION              167

9.2           BLOOD PRODUCTS         167

9.2.1        EASE OF COLLECTION AND ANALYTICAL VERSATILITY TO PROPEL MARKET      167

9.3           SOLID TISSUES & ORGANS           170

9.3.1        GROWTH IN SPATIAL OMICS TO FUEL MARKET                 170

9.4           STEM CELLS & CELL LINES          173

9.4.1        ADOPTION OF REGENERATIVE MEDICINE TO BOOST DEMAND             173

9.5           BIOLOGICAL FLUIDS     175

9.5.1        UTILIZATION FOR DISEASE-MECHANISM STUDIES TO FUEL UPTAKE   175

9.6           NUCLEIC ACIDS                178

9.6.1        INTEGRATION OF MULTI-OMICS TO BOOST DEMAND                 178

9.7           HUMAN WASTE PRODUCTS        181

9.7.1        APPLICATIONS ACROSS MICROBIOME RESEARCH TO FUEL UPTAKE   181

10            BIOBANKING PRODUCTS MARKET, BY END USER                 184

10.1         INTRODUCTION              185

10.2         BIOBANKS           185

10.2.1      GROWING FOCUS ON LIFE SCIENCES & CLINICAL RESEARCH TO BOOST DEMAND               185

10.3         CROS     188

10.3.1      GROWING FOCUS ON BIOMARKER TRIALS AND OUTSOURCING OF SERVICES TO SUPPORT MARKET      188

11            BIOBANKING SERVICES MARKET, BY OWNERSHIP                 192

11.1         INTRODUCTION              193

11.2         PRIVATE/COMMERCIAL BIOBANKS         193

11.2.1      TECHNOLOGICALLY ADVANCED INFRASTRUCTURE AND COMPLIANCE OFFERINGS TO PROPEL MARKET     193

11.3         ACADEMIC & RESEARCH INSTITUTION BIOBANKS                 196

11.3.1      FAVORABLE FUNDING ACTIVITIES TO BOOST DEMAND                 196

11.4         NATIONAL/REGIONAL AGENCIES            199

11.4.1      GOVERNMENT FOCUS ON ADVANCING HEALTHCARE RESEARCH INITIATIVES TO DRIVE MARKET        199

11.5         HYBRID/PPP MODELS   202

11.5.1      HIGH CREDIBILITY AND AGILITY TO SUPPORT MARKET GROWTH             202

11.6         OTHER OWNERSHIP MODELS    205

12            BIOBANKING MARKET, BY APPLICATION             208

12.1         INTRODUCTION              209

12.2         RESEARCH APPLICATIONS          209

12.2.1      LIFE SCIENCE RESEARCH              212

12.2.1.1  Increasing focus on genomics projects to fuel uptake     212

12.2.2      CLINICAL RESEARCH     215

12.2.2.1  Growing regulatory requirements and decentralized & hybrid trials to support market growth          215

12.3         THERAPEUTIC APPLICATIONS  218

12.3.1      GROWING DEMAND FOR CELL & GENE THERAPIES TO PROPEL MARKET             218

12.4         DIAGNOSTIC APPLICATIONS     220

12.4.1      REQUIREMENT OF DISEASE-SPECIFIC SAMPLES TO BOOST DEMAND             220

12.5         OTHER APPLICATIONS 223

13            BIOBANKING SERVICES MARKET, BY TYPE           226

13.1         INTRODUCTION              227

13.2         PHYSICAL BIOBANKING SERVICES           227

13.2.1      MEGA-COHORTS IN ONCOLOGY & POPULATION GENOMICS TO PROPEL MARKET              227

13.3         VIRTUAL BIOBANKING 230

13.3.1      EASE OF SPECIMEN ACCESS FOR END USERS TO DRIVE MARKET               230

13.4         OTHER SERVICES             233

14            BIOBANKING SERVICES MARKET, BY END USER                 236

14.1         INTRODUCTION              237

14.2         PHARMA-BIOTECH COMPANIES & CROS               237

14.2.1      EXPANDING DRUG DISCOVERY & DEVELOPMENT PIPELINE TO PROPEL MARKET 237

14.3         ACADEMIC & RESEARCH INSTITUTES    240

14.3.1      ADVANCEMENTS IN RESEARCH AND FAVORABLE GRANTS TO BOOST DEMAND   240

14.4         HOSPITALS & DIAGNOSTIC LABORATORIES       243

14.4.1      USE OF SAMPLES FOR THERAPEUTIC & DIAGNOSTIC PURPOSES TO AID MARKET        243

15            BIOBANKING MARKET, BY REGION         246

15.1         INTRODUCTION              247

15.2         NORTH AMERICA             247

15.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 253

15.2.2      US           254

15.2.2.1  US to dominate North American biobanking market during forecast period      254

15.2.3      CANADA               258

15.2.3.1  Strong public investment with national research networks and collaborations to support disease-focused biobanking   258

15.3         EUROPE               262

15.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      267

15.3.2      GERMANY           268

15.3.2.1  High government funding and focus on advanced clinical research to augment market growth  268

15.3.3      UK          273

15.3.3.1  Presence of large-scale, population-based advanced research infrastructure to propel market growth             273

15.3.4      FRANCE                277

15.3.4.1  Growing focus on quality standards, open science, and international collaboration to support market growth    277

15.3.5      ITALY    281

15.3.5.1  Improved healthcare standards to support biobanking studies in cancer, rare diseases, and personalized medicine healthcare         281

15.3.6      SPAIN    286

15.3.6.1  Adoption of international standards and advanced government-backed infrastructure to aid market growth     286

15.3.7      REST OF EUROPE             290

15.4         ASIA PACIFIC     294

15.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 300

15.4.2      CHINA  301

15.4.2.1  Increased research collaborations and advancements in biobank infrastructure to drive market             301

15.4.3      JAPAN   305

15.4.3.1  Strong genomic research output and focus on AI-driven polygenic risk scoring to boost predictive healthcare innovation  305

15.4.4      INDIA    309

15.4.4.1  National and disease-specific initiatives for advanced precision medicine and healthcare innovation to aid market growth            309

15.4.5      AUSTRALIA         314

15.4.5.1  Increasing national investments in disease-specific, microbiome, and wildlife biobanks to accelerate market growth          314

15.4.6      SOUTH KOREA  318

15.4.6.1  Increased quality standards and more international collaborations to support human and environmental biobanking          318

15.4.7      REST OF ASIA PACIFIC   323

15.5         LATIN AMERICA                327

15.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 332

15.5.2      BRAZIL 333

15.5.2.1  Genetic diversity and large-scale stem cell & genomic initiatives to propel market growth      333

15.5.3      MEXICO                337

15.5.3.1  Favorable initiatives for improving population health research and representation in global genomic databases to drive market 337

15.5.4      REST OF LATIN AMERICA             341

15.6         MIDDLE EAST   346

15.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST                 351

15.6.2      GCC COUNTRIES              352

15.6.2.1  Kingdom of Saudi Arabia (KSA)        357

15.6.2.1.1                Investments in automated equipment biobank infrastructure, ISO accreditation, and Vision 2030 to boost market growth                 357

15.6.2.2  UAE        361

15.6.2.2.1                Investments in AI-driven robotic biobanking to fuel market growth       361

15.6.2.3  Rest of GCC countries         365

15.6.3      REST OF MIDDLE EAST 371

15.7         AFRICA 376

15.7.1      GROWING STANDARDIZATION EFFORTS, INTERNATIONAL ACCREDITATION, AND CAPACITY-BUILDING TO PROPEL MARKET GROWTH 376

15.7.2      MACROECONOMIC OUTLOOK FOR AFRICA        380

16            COMPETITIVE LANDSCAPE         382

16.1         INTRODUCTION              382

16.2         KEY PLAYERS STRATEGIES/RIGHT TO WIN          382

16.3         REVENUE ANALYSIS, 2020–2024  384

16.3.1      REVENUE ANALYSIS FOR BIOBANKING PRODUCTS, 2020–2024              384

16.3.2      REVENUE ANALYSIS FOR BIOBANKING SERVICES & SOFTWARE, 2020–2024    386

16.4         MARKET SHARE ANALYSIS, 2024                 386

16.4.1      MARKET SHARE ANALYSIS FOR BIOBANKING PRODUCTS, 2024               386

16.4.2      MARKET SHARE ANALYSIS FOR BIOBANKING SERVICES & SOFTWARE, 2024           388

16.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 390

16.5.1      STARS   391

16.5.2      EMERGING LEADERS     391

16.5.3      PERVASIVE PLAYERS      391

16.5.4      PARTICIPANTS 391

16.5.5      COMPANY FOOTPRINT, KEY PLAYERS, 2024         393

16.5.5.1  Company footprint               393

16.5.5.2  Region footprint   394

16.5.5.3  Offering footprint 395

16.5.5.4  Sample type footprint           396

16.5.5.5  Workflow footprint               397

16.6         COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024        397

16.6.1      PROGRESSIVE COMPANIES         397

16.6.2      RESPONSIVE COMPANIES            397

16.6.3      DYNAMIC COMPANIES  398

16.6.4      STARTING BLOCKS         398

16.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 399

16.6.5.1  Detailed list of key startups/SMEs    399

16.6.5.2  Competitive benchmarking of startups/ SMEs                400

16.7         COMPANY VALUATION & FINANCIAL METRICS 401

16.7.1      COMPANY VALUATION & FINANCIAL METRICS FOR BIOBANKING PRODUCTS MARKET          401

16.7.1.1  Company valuation               401

16.7.1.2  Financial metrics  401

16.7.2      COMPANY VALUATION & FINANCIAL METRICS FOR BIOBANKING SERVICES & SOFTWARE MARKET 402

16.7.2.1  Company valuation               402

16.7.2.2  Financial metrics  402

16.8         BRAND/PRODUCT COMPARATIVE ANALYSIS     403

16.9         COMPETITIVE SCENARIO             404

16.9.1      PRODUCT/SERVICE/SOLUTION LAUNCHES        404

16.9.2      DEALS  405

16.9.3      EXPANSIONS     406

17            COMPANY PROFILES      407

17.1         KEY PLAYERS     407

17.1.1      THERMO FISHER SCIENTIFIC INC.            407

17.1.1.1  Business overview 407

17.1.1.2  Products/Services/Solutions offered 408

17.1.1.3  Recent developments           414

17.1.1.3.1                Product launches  414

17.1.1.3.2                Deals      415

17.1.1.3.3                Expansions             415

17.1.1.4  MnM view              416

17.1.1.4.1                Key strengths        416

17.1.1.4.2                Strategic choices   416

17.1.1.4.3                Weaknesses & competitive threats     416

17.1.2      PHC HOLDINGS CORPORATION               417

17.1.2.1  Business overview 417

17.1.2.2  Products/Services/Solutions offered 418

17.1.2.3  Recent developments           420

17.1.2.3.1                Product launches  420

17.1.2.4  MnM view              421

17.1.2.4.1                Key strengths        421

17.1.2.4.2                Strategic choices   421

17.1.2.4.3                Weaknesses & competitive threats     421

17.1.3      BECTON, DICKINSON AND COMPANY (BD)         422

17.1.3.1  Business overview 422

17.1.3.2  Products/Services/Solutions offered 423

17.1.3.3  Recent developments           425

17.1.3.3.1                Product launches  425

17.1.3.4  MnM view              426

17.1.3.4.1                Key strengths        426

17.1.3.4.2                Strategic choices   426

17.1.3.4.3                Weaknesses & competitive threats     426

17.1.4      QIAGEN                427

17.1.4.1  Business overview 427

17.1.4.2  Products/Services/Solutions offered 428

17.1.4.3  Recent developments           431

17.1.4.3.1                Product launches  431

17.1.4.4  MnM view              432

17.1.4.4.1                Key strengths        432

17.1.4.4.2                Strategic choices   432

17.1.4.4.3                Weaknesses & competitive threats     432

17.1.5      MERCK KGAA    433

17.1.5.1  Business overview 433

17.1.5.2  Products/Services/Solutions offered 434

17.1.5.3  Recent developments           436

17.1.5.3.1                Expansions             436

17.1.5.4  MnM view              436

17.1.5.4.1                Key strengths        436

17.1.5.4.2                Strategic choices   436

17.1.5.4.3                Weaknesses & competitive threats     436

17.1.6      AVANTOR, INC. 437

17.1.6.1  Business overview 437

17.1.6.2  Products/Services/Solutions offered 438

17.1.6.3  Recent developments           442

17.1.6.3.1                Deals      442

17.1.6.3.2                Expansions             442

17.1.7      CRYOPORT         443

17.1.7.1  Business overview 443

17.1.7.2  Products/Services/Solutions offered 444

17.1.7.3  Recent developments           446

17.1.7.3.1                Product launches  446

17.1.7.3.2                Deals      446

17.1.7.3.3                Expansions             448

17.1.8      TECAN TRADING AG      449

17.1.8.1  Business overview 449

17.1.8.2  Products/Services/Solutions offered 450

17.1.8.3  Recent developments           451

17.1.8.3.1                Product launches  451

17.1.9      AZENTA US INC.               453

17.1.9.1  Business overview 453

17.1.9.2  Products/Services/Solutions offered 454

17.1.9.3  Recent developments           455

17.1.9.3.1                Product launches  455

17.1.9.3.2                Deals      456

17.1.9.3.3                Expansions             456

17.1.10   GREINER AG       457

17.1.10.1                 Business overview 457

17.1.10.2                 Products/Services/Solutions offered 458

17.1.10.3                 Recent developments           459

17.1.10.3.1             Product launches  459

17.1.10.3.2             Expansions             460

17.1.11   AGILENT TECHNOLOGIES, INC.                461

17.1.11.1                 Business overview 461

17.1.11.2                 Products/Services/Solutions offered 462

17.1.12   LABCORP             463

17.1.12.1                 Business overview 463

17.1.12.2                 Products/Services/Solutions offered 464

17.1.12.3                 Recent developments           465

17.1.12.3.1             Deals      465

17.1.13   EUROFINS SCIENTIFIC  466

17.1.13.1                 Business overview 466

17.1.13.2                 Products/Services/Solutions offered 467

17.2         OTHER PLAYERS              468

17.2.1      HAIER BIOMEDICAL       468

17.2.2      HAMILTON COMPANY  469

17.2.3      AMSBIO                471

17.2.4      BAY BIOSCIENCES           472

17.2.5      BIOKRYO             473

17.2.6      SPT LABTECH LTD.         474

17.2.7      ASKION GMBH  475

17.2.8      CTIBIOTECH      476

17.2.9      CURELINE           477

17.2.10   FIRALIS MOLECULAR PRECISION             478

17.2.11   SOPACHEM         479

17.2.12   FROILABO           480

17.2.13   BIOIVT 481

18            APPENDIX           482

18.1         DISCUSSION GUIDE        482

18.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                487

18.3         CUSTOMIZATION OPTIONS        489

18.4         RELATED REPORTS         490

18.5         AUTHOR DETAILS           491

LIST OF TABLES

TABLE 1                BIOBANKING MARKET: INCLUSIONS & EXCLUSIONS      48

TABLE 2                IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS  61

TABLE 3                BIOBANKING MARKET: RISK ANALYSIS 65

TABLE 4                BIOBANKING MARKET: IMPACT ANALYSIS                 76

TABLE 5                AVERAGE SELLING PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER, 2024             82

TABLE 6                INDICATIVE PRICING OF BIOBANKING SERVICES, BY SERVICE TYPE, 2024             83

TABLE 7                INDICATIVE PRICING TREND FOR BIOBANKING PRODUCTS, BY REGION, 2022−2024 (USD)           83

TABLE 8                BIOBANKING MARKET: ROLE IN ECOSYSTEM                 86

TABLE 9                DETAILED ANALYSIS OF KEY PATENTS IN BIOBANKING MARKET, 2022–2025              90

TABLE 10              BIOBANKING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026                 93

TABLE 11              BIOBANKING MARKET: REGULATORY BODIES, GOVERNMENT

AGENCIES, AND OTHER ORGANIZATIONS           95

TABLE 12             IMPORT DATA FOR HS CODE 8418, BY COUNTRY, 2020–2024 (USD THOUSANDS)    96

TABLE 13             EXPORT DATA FOR HS CODE 8418, BY COUNTRY, 2020–2024 (USD THOUSANDS)    97

TABLE 14              BIOBANKING MARKET: PORTER’S FIVE FORCES                 97

TABLE 15              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING              100

TABLE 16              BUYING CRITERIA FOR BIOBANKING PRODUCTS MARKET, BY END USER         101

TABLE 17              BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER     103

TABLE 18              US ADJUSTED RECIPROCAL TARIFF RATES                 107

TABLE 19              BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 112

TABLE 20              BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            112

TABLE 21              BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            112

TABLE 22              BIOBANKING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)            113

TABLE 23              NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 24              EUROPE: BIOBANKING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 25              ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 26              LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            115

TABLE 27              MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            115

TABLE 28              GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            115

TABLE 29              BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY REGION,

2023–2030 (USD MILLION)            116

TABLE 30              NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               116

TABLE 31              EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY,

2023–2030 (USD MILLION)            117

TABLE 32              ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)            117

TABLE 33              LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)            117

TABLE 34              MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)            118

TABLE 35              GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY COUNTRY, 2023–2030 (USD MILLION)               118

TABLE 36              BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS, BY REGION,

2023–2030 (USD MILLION)            119

TABLE 37              NORTH AMERICA: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               119

TABLE 38              EUROPE: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               119

TABLE 39              ASIA PACIFIC: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               120

TABLE 40              LATIN AMERICA: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               120

TABLE 41              MIDDLE EAST: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,

BY REGION, 2023–2030 (USD MILLION)   120

TABLE 42              GCC COUNTRIES: BIOBANKING MARKET FOR FREEZERS & REFRIGERATORS,

BY COUNTRY, 2023–2030 (USD MILLION)               121

TABLE 43              BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY REGION,

2023–2030 (USD MILLION)            121

TABLE 44              NORTH AMERICA: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               122

TABLE 45              EUROPE: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               122

TABLE 46              ASIA PACIFIC: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               122

TABLE 47              LATIN AMERICA: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               123

TABLE 48              MIDDLE EAST: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,

BY REGION, 2023–2030 (USD MILLION)   123

TABLE 49              GCC COUNTRIES: BIOBANKING MARKET FOR CRYOGENIC STORAGE SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               123

TABLE 50              BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS, BY REGION,

2023–2030 (USD MILLION)            124

TABLE 51              NORTH AMERICA: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               124

TABLE 52              EUROPE: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               125

TABLE 53              ASIA PACIFIC: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               125

TABLE 54              LATIN AMERICA: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               125

TABLE 55              MIDDLE EAST: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,

BY REGION, 2023–2030 (USD MILLION)   126

TABLE 56              GCC COUNTRIES: BIOBANKING MARKET FOR ALARM & MONITORING SYSTEMS,

BY COUNTRY, 2023–2030 (USD MILLION)               126

TABLE 57              BIOBANKING MARKET FOR THAWING EQUIPMENT, BY REGION,

2023–2030 (USD MILLION)            127

TABLE 58              NORTH AMERICA: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)            127

TABLE 59              EUROPE: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY,

2023–2030 (USD MILLION)            127

TABLE 60              ASIA PACIFIC: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)            128

TABLE 61              LATIN AMERICA: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)            128

TABLE 62              MIDDLE EAST: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)                 128

TABLE 63              GCC COUNTRIES: BIOBANKING MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)            129

TABLE 64              BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS,

BY REGION, 2023–2030 (USD MILLION)   129

TABLE 65              NORTH AMERICA: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)            130

TABLE 66              EUROPE: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)            130

TABLE 67              ASIA PACIFIC: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)            130

TABLE 68              LATIN AMERICA: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)            131

TABLE 69              MIDDLE EAST: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION)            131

TABLE 70              GCC COUNTRIES: BIOBANKING MARKET FOR TEMPERATURE & HUMIDITY CONTROL SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)            131

TABLE 71              BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY REGION, 2023–2030 (USD MILLION)            132

TABLE 72              NORTH AMERICA: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 132

TABLE 73              EUROPE: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES,

BY COUNTRY, 2023–2030 (USD MILLION)               133

TABLE 74              ASIA PACIFIC: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES,

BY COUNTRY, 2023–2030 (USD MILLION)               133

TABLE 75              LATIN AMERICA: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 133

TABLE 76              MIDDLE EAST: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES,

BY REGION, 2023–2030 (USD MILLION)   134

TABLE 77              GCC COUNTRIES: BIOBANKING MARKET FOR OTHER EQUIPMENT & ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 134

TABLE 78              BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY REGION,

2023–2030 (USD MILLION)            135

TABLE 79              NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               135

TABLE 80              EUROPE: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)                 136

TABLE 81              ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               136

TABLE 82              LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               136

TABLE 83              MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2023–2030 (USD MILLION)            137

TABLE 84              GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 85              BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)            138

TABLE 86              NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            138

TABLE 87              EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 88              ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 89              LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 90             MIDDLE EAST: BIOBANKING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            140

TABLE 91              GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            140

TABLE 92              BIOBANKING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)            141

TABLE 93              NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            141

TABLE 94              EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            142

TABLE 95              ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            142

TABLE 96              LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            142

TABLE 97              MIDDLE EAST: BIOBANKING SOFTWARE MARKET, BY REGION,

2023–2030 (USD MILLION)            143

TABLE 98              GCC COUNTRIES: BIOBANKING SOFTWARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            143

TABLE 99              BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            145

TABLE 100            BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY REGION,

2023–2030 (USD MILLION)            146

TABLE 101            NORTH AMERICA: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 146

TABLE 102            EUROPE: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               146

TABLE 103            ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               147

TABLE 104            LATIN AMERICA: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               147

TABLE 105            MIDDLE EAST: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS,

BY REGION, 2023–2030 (USD MILLION)   147

TABLE 106            GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET FOR MANUAL OPERATIONS, BY REGION, 2023–2030 (USD MILLION) 148

TABLE 107            BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY REGION, 2023–2030 (USD MILLION)            149

TABLE 108            NORTH AMERICA: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       149

TABLE 109            EUROPE: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               149

TABLE 110            ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       150

TABLE 111            LATIN AMERICA: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       150

TABLE 112            MIDDLE EAST: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY REGION, 2023–2030 (USD MILLION)       150

TABLE 113            GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET FOR AUTOMATED OPERATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       151

TABLE 114            BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION) 153

TABLE 115            BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE,

BY REGION, 2023–2030 (USD MILLION)   154

TABLE 116            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023–2030 (USD MILLION)            154

TABLE 117            EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023–2030 (USD MILLION)       154

TABLE 118            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023–2030 (USD MILLION)            155

TABLE 119            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY COUNTRY, 2023–2030 (USD MILLION)            155

TABLE 120            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION & STORAGE, BY REGION, 2023–2030 (USD MILLION)            155

TABLE 121            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE COLLECTION AND STORAGE, BY REGION, 2023–2030 (USD MILLION)            156

TABLE 122            BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY REGION,

2023–2030 (USD MILLION)            157

TABLE 123            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 157

TABLE 124            EUROPE: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,

BY COUNTRY, 2023–2030 (USD MILLION)               157

TABLE 125            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,

BY COUNTRY, 2023–2030 (USD MILLION)               158

TABLE 126            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,

BY COUNTRY, 2023–2030 (USD MILLION)               158

TABLE 127            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,

BY REGION, 2023–2030 (USD MILLION)   158

TABLE 128            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SAMPLE PROCESSING,

BY COUNTRY, 2023–2030 (USD MILLION)               159

TABLE 129            BIOBANKING PRODUCTS MARKET FOR SAMPLE ANALYSIS, BY REGION,

2023–2030 (USD MILLION)            160

TABLE 130            NORTH AMERICA: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)                 160

TABLE 131            EUROPE: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY,

2023–2030 (USD MILLION)            160

TABLE 132            ASIA PACIFIC: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY,

2023–2030 (USD MILLION)            161

TABLE 133            LATIN AMERICA: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)                 161

TABLE 134            MIDDLE EAST: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY REGION,

2023–2030 (USD MILLION)            161

TABLE 135            GCC COUNTRIES: BIOBANKING MARKET FOR SAMPLE ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION)                 162

TABLE 136            BIOBANKING PRODUCTS MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2023–2030 (USD MILLION)            163

TABLE 137            NORTH AMERICA: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               163

TABLE 138            EUROPE: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023–2030 (USD MILLION)            163

TABLE 139            ASIA PACIFIC: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY COUNTRY, 2023–2030 (USD MILLION)            164

TABLE 140            LATIN AMERICA: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               164

TABLE 141            MIDDLE EAST: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS, BY REGION, 2023–2030 (USD MILLION)            164

TABLE 142            GCC COUNTRIES: BIOBANKING MARKET FOR TRANSPORT & LOGISTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               165

TABLE 143            BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)                167

TABLE 144            BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY REGION,

2023–2030 (USD MILLION)            168

TABLE 145            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,

BY REGION, 2023–2030 (USD MILLION)   168

TABLE 146            EUROPE: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)            168

TABLE 147            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,

BY COUNTRY, 2023–2030 (USD MILLION)               169

TABLE 148            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,

BY COUNTRY, 2023–2030 (USD MILLION)               169

TABLE 149            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,

BY REGION, 2023–2030 (USD MILLION)   169

TABLE 150            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BLOOD PRODUCTS,

BY COUNTRY, 2023–2030 (USD MILLION)               170

TABLE 151            BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2023–2030 (USD MILLION)                 170

TABLE 152            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION)       171

TABLE 153            EUROPE: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 154            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION)       171

TABLE 155            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION)       172

TABLE 156            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY REGION, 2023–2030 (USD MILLION) 172

TABLE 157            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR SOLID TISSUES & ORGANS, BY COUNTRY, 2023–2030 (USD MILLION)       172

TABLE 158            BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY REGION, 2023–2030 (USD MILLION)                 173

TABLE 159            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION)       173

TABLE 160            EUROPE: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES,

BY COUNTRY, 2023–2030 (USD MILLION)               174

TABLE 161            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR STEM CELLS & CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION)       174

TABLE 162            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR STEM CELLS &

CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION)     174

TABLE 163            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR STEM CELLS &

CELL LINES, BY REGION, 2023–2030 (USD MILLION)         175

TABLE 164            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR STEM CELLS &

CELL LINES, BY COUNTRY, 2023–2030 (USD MILLION)     175

TABLE 165            BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS, BY REGION,

2023–2030 (USD MILLION)            176

TABLE 166            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,

BY COUNTRY, 2023–2030 (USD MILLION)               176

TABLE 167            EUROPE: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,

BY COUNTRY, 2023–2030 (USD MILLION)               176

TABLE 168            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,

BY COUNTRY, 2023–2030 (USD MILLION)               177

TABLE 169            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,

BY COUNTRY, 2023–2030 (USD MILLION)             177

TABLE 170            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,

BY REGION, 2023–2030 (USD MILLION)   177

TABLE 171            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BIOLOGICAL FLUIDS,

BY COUNTRY, 2023–2030 (USD MILLION)               178

TABLE 172            BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY REGION,

2023–2030 (USD MILLION)            178

TABLE 173            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,

BY COUNTRY, 2023–2030 (USD MILLION)               179

TABLE 174            EUROPE: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2023–2030 (USD MILLION)                 179

TABLE 175            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,

BY COUNTRY, 2023–2030 (USD MILLION)               179

TABLE 176            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,

BY COUNTRY, 2023–2030 (USD MILLION)               180

TABLE 177            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,

BY REGION, 2023–2030 (USD MILLION)   180

TABLE 178            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR NUCLEIC ACIDS,

BY COUNTRY, 2023–2030 (USD MILLION)               180

TABLE 179            BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2023–2030 (USD MILLION)                 181

TABLE 180            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)       181

TABLE 181            EUROPE: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS,

BY COUNTRY, 2023–2030 (USD MILLION)               182

TABLE 182            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)       182

TABLE 183            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)       182

TABLE 184            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2023–2030 (USD MILLION)       183

TABLE 185            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)       183

TABLE 186            BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                185

TABLE 187            BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY REGION,

2023–2030 (USD MILLION)            186

TABLE 188            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)            186

TABLE 189            EUROPE: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY,

2023–2030 (USD MILLION)            186

TABLE 190            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)            187

TABLE 191            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)            187

TABLE 192            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY REGION, 2023–2030 (USD MILLION)                 187

TABLE 193            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)            188

TABLE 194            BIOBANKING PRODUCTS MARKET FOR CROS, BY REGION,

2023–2030 (USD MILLION)            189

TABLE 195            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)                 189

TABLE 196            EUROPE: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 197            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY,

2023–2030 (USD MILLION)            190

TABLE 198            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)                 190

TABLE 199            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR CROS, BY REGION,

2023–2030 (USD MILLION)            190

TABLE 200            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)                 191

TABLE 201            BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 193

TABLE 202            BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS,

BY REGION, 2023–2030 (USD MILLION)   194

TABLE 203            NORTH AMERICA: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)            194

TABLE 204            EUROPE: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION) 194

TABLE 205            ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)       195

TABLE 206            LATIN AMERICA: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)            195

TABLE 207            MIDDLE EAST: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 195

TABLE 208            GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR PRIVATE/COMMERCIAL BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)            196

TABLE 209            BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY REGION, 2023–2030 (USD MILLION)            197

TABLE 210            NORTH AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)               197

TABLE 211            EUROPE: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)     197

TABLE 212            ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)     198

TABLE 213            LATIN AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)               198

TABLE 214            MIDDLE EAST: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY REGION, 2023–2030 (USD MILLION)          198

TABLE 215            GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTION BIOBANKS, BY COUNTRY, 2023–2030 (USD MILLION)               199

TABLE 216            BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY REGION, 2023–2030 (USD MILLION)            200

TABLE 217            NORTH AMERICA: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION)            200

TABLE 218            EUROPE: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION) 200

TABLE 219            ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION) 201

TABLE 220            LATIN AMERICA: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION)            201

TABLE 221            MIDDLE EAST: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY REGION, 2023–2030 (USD MILLION) 201

TABLE 222            GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR NATIONAL/REGIONAL AGENCIES, BY COUNTRY, 2023–2030 (USD MILLION)            202

TABLE 223            BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS, BY REGION,

2023–2030 (USD MILLION)            203

TABLE 224            NORTH AMERICA: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS,

BY COUNTRY, 2023–2030 (USD MILLION)               203

TABLE 225            EUROPE: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS,

BY COUNTRY, 2023–2030 (USD MILLION)               203

TABLE 226            ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 227            LATIN AMERICA: BIOBANKING SERVICES MARKET FOR HYBRID/PPP MODELS,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 228            MIDDLE EAST: BIOBANKING SERVICES MARKET FOR HYBRID/PPP BIOBANKS,

BY REGION, 2023–2030 (USD MILLION)   204

TABLE 229            GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR HYBRID/PPP BIOBANKS, BY REGION, 2023–2030 (USD MILLION) 205

TABLE 230            BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY REGION, 2023–2030 (USD MILLION)                 205

TABLE 231            NORTH AMERICA: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION)            206

TABLE 232            EUROPE: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS,

BY COUNTRY, 2023–2030 (USD MILLION)               206

TABLE 233            ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION) 206

TABLE 234            LATIN AMERICA: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION)            207

TABLE 235            MIDDLE EAST: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY REGION, 2023–2030 (USD MILLION)            207

TABLE 236            GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR OTHER OWNERSHIP MODELS, BY COUNTRY, 2023–2030 (USD MILLION)            207

TABLE 237            BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)       209

TABLE 238            BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            210

TABLE 239            NORTH AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               210

TABLE 240            EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 210

TABLE 241            ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            211

TABLE 242            LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 243            MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY REGION, 2023–2030 (USD MILLION)   211

TABLE 244            GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 245            BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH,

BY REGION, 2023–2030 (USD MILLION)   213

TABLE 246            NORTH AMERICA: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 213

TABLE 247            EUROPE: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               213

TABLE 248            ASIA PACIFIC: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 214

TABLE 249            LATIN AMERICA: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 214

TABLE 250            MIDDLE EAST: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2023–2030 (USD MILLION) 214

TABLE 251            GCC COUNTRIES: BIOBANKING APPLICATIONS MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 215

TABLE 252            BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY REGION, 2023–2030 (USD MILLION)                 215

TABLE 253            NORTH AMERICA: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 216

TABLE 254            EUROPE: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               216

TABLE 255            ASIA PACIFIC: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               216

TABLE 256            LATIN AMERICA: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 217

TABLE 257            MIDDLE EAST: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH,

BY REGION, 2023–2030 (USD MILLION)   217

TABLE 258            GCC COUNTRIES: BIOBANKING APPLICATIONS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 217

TABLE 259            BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            218

TABLE 260            NORTH AMERICA: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               218

TABLE 261            EUROPE: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            219

TABLE 262            ASIA PACIFIC: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               219

TABLE 263            LATIN AMERICA: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               219

TABLE 264            MIDDLE EAST: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,

BY REGION, 2023–2030 (USD MILLION)   220

TABLE 265            GCC COUNTRIES: BIOBANKING MARKET FOR THERAPEUTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               220

TABLE 266            BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            221

TABLE 267            NORTH AMERICA: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               221

TABLE 268            EUROPE: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            221

TABLE 269            ASIA PACIFIC: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 270            LATIN AMERICA: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 271            MIDDLE EAST: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,

BY REGION, 2023–2030 (USD MILLION)   222

TABLE 272            GCC COUNTRIES: BIOBANKING MARKET FOR DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               223

TABLE 273            BIOBANKING MARKET FOR OTHER APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            223

TABLE 274            NORTH AMERICA: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            224

TABLE 275            EUROPE: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            224

TABLE 276            ASIA PACIFIC: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            224

TABLE 277            LATIN AMERICA: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            225

TABLE 278            MIDDLE EAST: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)                 225

TABLE 279            GCC COUNTRIES: BIOBANKING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            225

TABLE 280            BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            227

TABLE 281            PHYSICAL BIOBANKING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            228

TABLE 282            NORTH AMERICA: PHYSICAL BIOBANKING SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               228

TABLE 283            EUROPE: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            228

TABLE 284            ASIA PACIFIC: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            229

TABLE 285            LATIN AMERICA: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            229

TABLE 286            MIDDLE EAST: PHYSICAL BIOBANKING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            229

TABLE 287            GCC COUNTRIES: PHYSICAL BIOBANKING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 230

TABLE 288            VIRTUAL BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          230

TABLE 289            NORTH AMERICA: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            231

TABLE 290            EUROPE: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            231

TABLE 291            ASIA PACIFIC: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            231

TABLE 292            LATIN AMERICA: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            232

TABLE 293            MIDDLE EAST: VIRTUAL BIOBANKING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            232

TABLE 294            GCC COUNTRIES: VIRTUAL BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            232

TABLE 295            OTHER BIOBANKING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          233

TABLE 296            NORTH AMERICA: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            233

TABLE 297            EUROPE: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            234

TABLE 298            ASIA PACIFIC: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            234

TABLE 299            LATIN AMERICA: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            234

TABLE 300            MIDDLE EAST: OTHER BIOBANKING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            235

TABLE 301            GCC COUNTRIES: OTHER BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            235

TABLE 302            BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)            237

TABLE 303            BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS,

BY REGION, 2023–2030 (USD MILLION)   238

TABLE 304            NORTH AMERICA: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION)     238

TABLE 305            EUROPE: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION)       238

TABLE 306            ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION)            239

TABLE 307            LATIN AMERICA: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION)     239

TABLE 308            MIDDLE EAST: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY REGION, 2023–2030 (USD MILLION)       239

TABLE 309            GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR PHARMA-BIOTECH COMPANIES & CROS, BY COUNTRY, 2023–2030 (USD MILLION)     240

TABLE 310            BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 240

TABLE 311            NORTH AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     241

TABLE 312            EUROPE: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 241

TABLE 313            ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)       241

TABLE 314            LATIN AMERICA: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     242

TABLE 315            MIDDLE EAST: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)       242

TABLE 316            GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     242

TABLE 317            BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)       243

TABLE 318            NORTH AMERICA: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)     243

TABLE 319            EUROPE: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            244

TABLE 320            ASIA PACIFIC: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            244

TABLE 321            LATIN AMERICA: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)     244

TABLE 322            MIDDLE EAST: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)            245

TABLE 323            GCC COUNTRIES: BIOBANKING SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)     245

TABLE 324            BIOBANKING MARKET, BY REGION, 2023–2030 (USD MILLION) 247

TABLE 325            NORTH AMERICA: BIOBANKING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            248

TABLE 326            NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            249

TABLE 327            NORTH AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         249

TABLE 328            NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            249

TABLE 329            NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            250

TABLE 330            NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            250

TABLE 331            NORTH AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            251

TABLE 332            NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            251

TABLE 333            NORTH AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         251

TABLE 334            NORTH AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            252

TABLE 335            NORTH AMERICA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            252

TABLE 336            NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            252

TABLE 337            NORTH AMERICA: KEY MACROINDICATORS                 253

TABLE 338            US: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)       254

TABLE 339            US: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            254

TABLE 340            US: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            255

TABLE 341            US: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            255

TABLE 342            US: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            255

TABLE 343            US: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            256

TABLE 344            US: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            256

TABLE 345            US: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 256

TABLE 346            US: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            257

TABLE 347            US: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            257

TABLE 348            US: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                257

TABLE 349            US: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                258

TABLE 350            CANADA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            258

TABLE 351            CANADA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                259

TABLE 352            CANADA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            259

TABLE 353            CANADA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            259

TABLE 354            CANADA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            260

TABLE 355            CANADA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            260

TABLE 356            CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                260

TABLE 357            CANADA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            261

TABLE 358            CANADA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              261

TABLE 359            CANADA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            261

TABLE 360            CANADA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            262

TABLE 361            CANADA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            262

TABLE 362            EUROPE: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            263

TABLE 363            EUROPE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                263

TABLE 364            EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            263

TABLE 365            EUROPE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)          264

TABLE 366            EUROPE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            264

TABLE 367            EUROPE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            264

TABLE 368            EUROPE: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                265

TABLE 369            EUROPE: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            265

TABLE 370            EUROPE: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              265

TABLE 371            EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            266

TABLE 372            EUROPE: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            266

TABLE 373            EUROPE: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            266

TABLE 374            EUROPE: BIOBANKING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            267

TABLE 375            EUROPE: KEY MACROINDICATORS          268

TABLE 376            GERMANY: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)     269

TABLE 377            GERMANY: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            269

TABLE 378            GERMANY: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            269

TABLE 379            GERMANY: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            270

TABLE 380            GERMANY: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)          270

TABLE 381            GERMANY: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            270

TABLE 382            GERMANY: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                271

TABLE 383            GERMANY: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            271

TABLE 384            GERMANY: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              271

TABLE 385            GERMANY: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            272

TABLE 386            GERMANY: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            272

TABLE 387            GERMANY: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            272

TABLE 388            UK: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)       273

TABLE 389          UK: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            273

TABLE 390            UK: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            274

TABLE 391            UK: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            274

TABLE 392            UK: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            274

TABLE 393            UK: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            275

TABLE 394            UK: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            275

TABLE 395            UK: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION) 275

TABLE 396            UK: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            276

TABLE 397            UK: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            276

TABLE 398            UK: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                276

TABLE 399            UK: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                277

TABLE 400            FRANCE: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            277

TABLE 401            FRANCE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                278

TABLE 402            FRANCE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            278

TABLE 403            FRANCE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            278

TABLE 404            FRANCE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            279

TABLE 405            FRANCE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            279

TABLE 406            FRANCE: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                279

TABLE 407            FRANCE: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            280

TABLE 408            FRANCE: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              280

TABLE 409            FRANCE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            280

TABLE 410            FRANCE: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            281

TABLE 411            FRANCE: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            281

TABLE 412            ITALY: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            282

TABLE 413            ITALY: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                282

TABLE 414            ITALY: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            282

TABLE 415            ITALY: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            283

TABLE 416            ITALY: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            283

TABLE 417            ITALY: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            283

TABLE 418            ITALY: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                284

TABLE 419            ITALY: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            284

TABLE 420          ITALY: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            284

TABLE 421            ITALY: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            285

TABLE 422            ITALY: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            285

TABLE 423            ITALY: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            285

TABLE 424            SPAIN: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            286

TABLE 425            SPAIN: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                286

TABLE 426            SPAIN: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            287

TABLE 427            SPAIN: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            287

TABLE 428            SPAIN: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            287

TABLE 429            SPAIN: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            288

TABLE 430            SPAIN: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                288

TABLE 431            SPAIN: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            288

TABLE 432          SPAIN: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            289

TABLE 433            SPAIN: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         289

TABLE 434            SPAIN: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            289

TABLE 435            SPAIN: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            290

TABLE 436            REST OF EUROPE: BIOBANKING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            290

TABLE 437            REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            291

TABLE 438            REST OF EUROPE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         291

TABLE 439            REST OF EUROPE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION)                 291

TABLE 440            REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            292

TABLE 441            REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            292

TABLE 442            REST OF EUROPE: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            292

TABLE 443            REST OF EUROPE: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            293

TABLE 444            REST OF EUROPE: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            293

TABLE 445            REST OF EUROPE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         293

TABLE 446            REST OF EUROPE: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            294

TABLE 447            REST OF EUROPE: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            294

TABLE 448            ASIA PACIFIC: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)     295

TABLE 449            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            296

TABLE 450            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            296

TABLE 451            ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            296

TABLE 452            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            297

TABLE 453            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            297

TABLE 454            ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            297

TABLE 455            ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            298

TABLE 456            ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              298

TABLE 457            ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 298

TABLE 458            ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            299

TABLE 459            ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            299

TABLE 460            ASIA PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     299

TABLE 461            ASIA PACIFIC: KEY MACROINDICATORS                 300

TABLE 462            CHINA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            301

TABLE 463            CHINA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                301

TABLE 464            CHINA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            302

TABLE 465            CHINA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            302

TABLE 466            CHINA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            302

TABLE 467            CHINA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            303

TABLE 468            CHINA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                303

TABLE 469            CHINA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            303

TABLE 470            CHINA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              304

TABLE 471            CHINA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            304

TABLE 472            CHINA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            304

TABLE 473            CHINA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            305

TABLE 474            JAPAN: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            305

TABLE 475            JAPAN: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                306

TABLE 476            JAPAN: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            306

TABLE 477            JAPAN: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            306

TABLE 478            JAPAN: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            307

TABLE 479            JAPAN: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            307

TABLE 480            JAPAN: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                307

TABLE 481            JAPAN: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            308

TABLE 482            JAPAN: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              308

TABLE 483            JAPAN: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            308

TABLE 484            JAPAN: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            309

TABLE 485            JAPAN: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            309

TABLE 486            INDIA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            310

TABLE 487            INDIA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                310

TABLE 488            INDIA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 489            INDIA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            311

TABLE 490            INDIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            311

TABLE 491            INDIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            311

TABLE 492            INDIA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                312

TABLE 493            INDIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            312

TABLE 494          INDIA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            312

TABLE 495            INDIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            313

TABLE 496            INDIA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            313

TABLE 497            INDIA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            313

TABLE 498            AUSTRALIA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)     314

TABLE 499            AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            314

TABLE 500            AUSTRALIA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            315

TABLE 501            AUSTRALIA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            315

TABLE 502            AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            315

TABLE 503            AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            316

TABLE 504            AUSTRALIA: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            316

TABLE 505            AUSTRALIA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            317

TABLE 506            AUSTRALIA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              317

TABLE 507            AUSTRALIA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         317

TABLE 508            AUSTRALIA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            318

TABLE 509            AUSTRALIA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            318

TABLE 510            SOUTH KOREA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)     319

TABLE 511            SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            319

TABLE 512            SOUTH KOREA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 319

TABLE 513            SOUTH KOREA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            320

TABLE 514            SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            320

TABLE 515            SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            320

TABLE 516            SOUTH KOREA: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            321

TABLE 517            SOUTH KOREA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            321

TABLE 518            SOUTH KOREA: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            321

TABLE 519            SOUTH KOREA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         322

TABLE 520            SOUTH KOREA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            322

TABLE 521            SOUTH KOREA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            322

TABLE 522            REST OF ASIA PACIFIC: BIOBANKING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            323

TABLE 523            REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            323

TABLE 524            REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)       324

TABLE 525            REST OF ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION)            324

TABLE 526            REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            324

TABLE 527            REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)            325

TABLE 528            REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            325

TABLE 529            REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)          326

TABLE 530            REST OF ASIA PACIFIC: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            326

TABLE 531            REST OF ASIA PACIFIC: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)       326

TABLE 532            REST OF ASIA PACIFIC: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            327

TABLE 533            REST OF ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            327

TABLE 534            LATIN AMERICA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)     328

TABLE 535            LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            328

TABLE 536            LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         328

TABLE 537            LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            329

TABLE 538            LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            329

TABLE 539            LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            329

TABLE 540            LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)          330

TABLE 541            LATIN AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            330

TABLE 542            LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            330

TABLE 543            LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 331

TABLE 544            LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            331

TABLE 545            LATIN AMERICA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            331

TABLE 546            LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            332

TABLE 547            LATIN AMERICA: KEY MACROINDICATORS                 333

TABLE 548            BRAZIL: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            333

TABLE 549            BRAZIL: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                334

TABLE 550            BRAZIL: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            334

TABLE 551            BRAZIL: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            334

TABLE 552            BRAZIL: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            335

TABLE 553            BRAZIL: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            335

TABLE 554            BRAZIL: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                335

TABLE 555            BRAZIL: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            336

TABLE 556            BRAZIL: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              336

TABLE 557            BRAZIL: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)          336

TABLE 558            BRAZIL: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            337

TABLE 559            BRAZIL: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            337

TABLE 560            MEXICO: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            338

TABLE 561            MEXICO: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                338

TABLE 562            MEXICO: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         338

TABLE 563            MEXICO: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            339

TABLE 564            MEXICO: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            339

TABLE 565            MEXICO: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            339

TABLE 566            MEXICO: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                340

TABLE 567            MEXICO: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            340

TABLE 568            MEXICO: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              340

TABLE 569            MEXICO: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            341

TABLE 570            MEXICO: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            341

TABLE 571            MEXICO: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            341

TABLE 572            REST OF LATIN AMERICA: BIOBANKING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            342

TABLE 573            REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            342

TABLE 574            REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         342

TABLE 575            REST OF LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION)            343

TABLE 576            REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 343

TABLE 577            REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)            343

TABLE 578            REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            344

TABLE 579            REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION)                 344

TABLE 580            REST OF LATIN AMERICA: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            345

TABLE 581            REST OF LATIN AMERICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 345

TABLE 582            REST OF LATIN AMERICA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            345

TABLE 583            REST OF LATIN AMERICA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            346

TABLE 584            MIDDLE EAST: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)     346

TABLE 585            MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            347

TABLE 586            MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 347

TABLE 587            MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            347

TABLE 588            MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            348

TABLE 589            MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            348

TABLE 590          MIDDLE EAST: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            348

TABLE 591          MIDDLE EAST: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            349

TABLE 592            MIDDLE EAST: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            349

TABLE 593            MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         349

TABLE 594            MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            350

TABLE 595          MIDDLE EAST: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            350

TABLE 596            MIDDLE EAST: BIOBANKING MARKET, BY REGION, 2023–2030 (USD MILLION)          350

TABLE 597            MIDDLE EAST: KEY MACROINDICATORS                 351

TABLE 598            GCC COUNTRIES: BIOBANKING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            352

TABLE 599            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            352

TABLE 600            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                 353

TABLE 601            GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            353

TABLE 602            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            353

TABLE 603            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            354

TABLE 604            GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            354

TABLE 605            GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            355

TABLE 606            GCC COUNTRIES: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            355

TABLE 607            GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 355

TABLE 608            GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            356

TABLE 609            GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            356

TABLE 610            GCC COUNTRIES: BIOBANKING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     356

TABLE 611            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            357

TABLE 612            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            357

TABLE 613            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            358

TABLE 614            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING EQUIPMENT MARKET,

BY OPERATION TYPE, 2023–2030 (USD MILLION)               358

TABLE 615            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           358

TABLE 616            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       359

TABLE 617            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING SERVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         359

TABLE 618            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING SERVICES MARKET,

BY OWNERSHIP, 2023–2030 (USD MILLION)          360

TABLE 619            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            360

TABLE 620            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            360

TABLE 621            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)             361

TABLE 622            KINGDOM OF SAUDI ARABIA (KSA): BIOBANKING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               361

TABLE 623            UAE: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            362

TABLE 624            UAE: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                362

TABLE 625            UAE: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            362

TABLE 626            UAE: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            363

TABLE 627            UAE: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            363

TABLE 628            UAE: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            363

TABLE 629            UAE: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            364

TABLE 630            UAE: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            364

TABLE 631            UAE: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            364

TABLE 632            UAE: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)            365

TABLE 633            UAE: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)     365

TABLE 634            UAE: BIOBANKING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                365

TABLE 635            REST OF GCC COUNTRIES: BIOBANKING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            366

TABLE 636            REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            366

TABLE 637            REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         367

TABLE 638            REST OF GCC COUNTRIES: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION)            367

TABLE 639            REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 367

TABLE 640            REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)            368

TABLE 641            REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            368

TABLE 642            REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY OWNERSHIP, 2023–2030 (USD MILLION)                 369

TABLE 643            REST OF GCC COUNTRIES: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            369

TABLE 644            REST OF GCC COUNTRIES: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 369

TABLE 645            REST OF GCC COUNTRIES: BIOBANKING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                 370

TABLE 646            REST OF GCC COUNTRIES: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            371

TABLE 647            REST OF MIDDLE EAST: BIOBANKING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            371

TABLE 648            REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            372

TABLE 649            REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         372

TABLE 650            REST OF MIDDLE EAST: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE, 2023–2030 (USD MILLION)            372

TABLE 651            REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            373

TABLE 652            REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)            373

TABLE 653            REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            374

TABLE 654            REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            374

TABLE 655            REST OF MIDDLE EAST: BIOBANKING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            375

TABLE 656            REST OF MIDDLE EAST: BIOBANKING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         375

TABLE 657            REST OF MIDDLE EAST: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            375

TABLE 658            REST OF MIDDLE EAST: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            376

TABLE 659            AFRICA: BIOBANKING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            377

TABLE 660            AFRICA: BIOBANKING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                377

TABLE 661            AFRICA: BIOBANKING PRODUCTS MARKET FOR EQUIPMENT, BY TYPE,

2023–2030 (USD MILLION)            377

TABLE 662            AFRICA: BIOBANKING EQUIPMENT MARKET, BY OPERATION TYPE,

2023–2030 (USD MILLION)            378

TABLE 663            AFRICA: BIOBANKING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            378

TABLE 664            AFRICA: BIOBANKING PRODUCTS MARKET, BY SAMPLE TYPE,

2023–2030 (USD MILLION)            378

TABLE 665            AFRICA: BIOBANKING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                379

TABLE 666            AFRICA: BIOBANKING SERVICES MARKET, BY OWNERSHIP,

2023–2030 (USD MILLION)            379

TABLE 667            AFRICA: BIOBANKING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              379

TABLE 668            AFRICA: BIOBANKING MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2030 (USD MILLION)          380

TABLE 669            AFRICA: BIOBANKING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            380

TABLE 670            AFRICA: BIOBANKING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            380

TABLE 671            AFRICA: KEY MACROINDICATORS            381

TABLE 672            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN

THE BIOBANKING MARKET         382

TABLE 673            BIOBANKING PRODUCTS MARKET: DEGREE OF COMPETITION 387

TABLE 674            BIOBANKING SERVICES & SOFTWARE MARKET: DEGREE OF COMPETITION         389

TABLE 675            BIOBANKING MARKET: REGION FOOTPRINT                 394

TABLE 676            BIOBANKING MARKET: OFFERING FOOTPRINT                 395

TABLE 677            BIOBANKING MARKET: SAMPLE TYPE FOOTPRINT       396

TABLE 678            BIOBANKING MARKET: WORKFLOW FOOTPRINT       397

TABLE 679            BIOBANKING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS             399

TABLE 680            BIOBANKING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION     400

TABLE 681            BIOBANKING MARKET: PRODUCT/SERVICE/SOFTWARE

LAUNCHES, JANUARY 2021–JULY 2025     404

TABLE 682            BIOBANKING MARKET: DEALS, JANUARY 2021–JULY 2025             405

TABLE 683            BIOBANKING MARKET: EXPANSIONS, JANUARY 2021–JULY 2025  406

TABLE 684            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          407

TABLE 685            THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    408

TABLE 686            THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,

JANUARY 2021–JULY 2025               414

TABLE 688          THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JULY 2025               415

TABLE 689            PHC HOLDINGS CORPORATION: COMPANY OVERVIEW          417

TABLE 690            PHC HOLDINGS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED    418

TABLE 691            PHC HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025     420

TABLE 692            BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW   422

TABLE 693            BECTON, DICKINSON AND COMPANY (BD): PRODUCTS/SERVICES/

SOLUTIONS OFFERED   423

TABLE 694            BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES,

JANUARY 2021–JULY 2025               425

TABLE 695            QIAGEN: COMPANY OVERVIEW 427

TABLE 696            QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED             428

TABLE 697            QIAGEN: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025             431

TABLE 699            MERCK KGAA: COMPANY OVERVIEW     433

TABLE 700            MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED    434

TABLE 701            MERCK KGAA: EXPANSIONS, JANUARY 2021–JULY 2025             436

TABLE 702            AVANTOR, INC.: COMPANY OVERVIEW 437

TABLE 703            AVANTOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    438

TABLE 704            AVANTOR, INC.: DEALS, JANUARY 2021–JULY 2025        442

TABLE 705            AVANTOR, INC.: EXPANSIONS, JANUARY 2021–JULY 2025             442

TABLE 706            CRYOPORT: COMPANY OVERVIEW          443

TABLE 707            CRYOPORT: PRODUCTS/SERVICES/SOLUTIONS OFFERED             444

TABLE 708            CRYOPORT: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025  446

TABLE 709            CRYOPORT: DEALS, JANUARY 2021–JULY 2025                 446

TABLE 710            CRYOPORT: EXPANSIONS, JANUARY 2021–JULY 2025        448

TABLE 711            TECAN TRADING AG: COMPANY OVERVIEW                 449

TABLE 712            TECAN TRADING AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED    450

TABLE 713            TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025               451

TABLE 714            TECAN TRADING AG: DEALS, JANUARY 2021–JULY 2025             452

TABLE 715            AZENTA US INC.: COMPANY OVERVIEW                 453

TABLE 716            AZENTA US INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    454

TABLE 717            AZENTA US INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025               455

TABLE 718            AZENTA US INC.: DEALS, JANUARY 2021–JULY 2025        456

TABLE 719            AZENTA US INC.: EXPANSIONS, JANUARY 2021–JULY 2025             456

TABLE 720            GREINER AG: COMPANY OVERVIEW       457

TABLE 721            GREINER AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED    458

TABLE 722            GREINER AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025  459

TABLE 723            GREINER AG: EXPANSIONS, JANUARY 2021–JULY 2025        460

TABLE 724            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          461

TABLE 725            AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    462

TABLE 726            LABCORP: COMPANY OVERVIEW             463

TABLE 727            LABCORP: PRODUCTS/SERVICES/SOLUTIONS OFFERED             464

TABLE 728            LABCORP: DEALS, JANUARY 2021–JULY 2025                 465

TABLE 729            EUROFINS SCIENTIFIC: COMPANY OVERVIEW                 466

TABLE 730            EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED    467

TABLE 731            HAIER BIOMEDICAL: COMPANY OVERVIEW                 468

TABLE 732            HAMILTON COMPANY: COMPANY OVERVIEW                 469

TABLE 733            AMSBIO: COMPANY OVERVIEW 471

TABLE 734            BAY BIOSCIENCES: COMPANY OVERVIEW                 472

TABLE 735            BIOKRYO: COMPANY OVERVIEW              473

TABLE 736            SPT LABTECH LTD.: COMPANY OVERVIEW                 474

TABLE 737            ASKION GMBH: COMPANY OVERVIEW   475

TABLE 738            CTIBIOTECH: COMPANY OVERVIEW      476

TABLE 739            CURELINE: COMPANY OVERVIEW            477

TABLE 740            FIRALIS MOLECULAR PRECISION: COMPANY OVERVIEW          478

TABLE 741            SOPACHEM: COMPANY OVERVIEW         479

TABLE 742            FROILABO: COMPANY OVERVIEW            480

TABLE 743            BIOIVT: COMPANY OVERVIEW  481

LIST OF FIGURES

FIGURE 1              BIOBANKING MARKET SEGMENTATION & REGIONAL SCOPE            47

FIGURE 2              BIOBANKING MARKET: YEARS CONSIDERED                 49

FIGURE 3              BIOBANKING MARKET: RESEARCH DESIGN                 52

FIGURE 4              BIOBANKING MARKET: BREAKDOWN OF PRIMARIES

(SUPPLY- AND DEMAND-SIDE PARTICIPANTS) 54

FIGURE 5              BIOBANKING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024  55

FIGURE 6              BIOBANKING PRODUCTS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024             56

FIGURE 7              BIOBANKING SERVICES & SOFTWARE MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024      56

FIGURE 8              ILLUSTRATIVE EXAMPLE OF CRYOPORT, INC.: REVENUE SHARE ANALYSIS, 2024               57

FIGURE 9              BIOBANKING MARKET SIZE VALIDATION FROM PRIMARY SOURCES         58

FIGURE 10            BIOBANKING MARKET: SEGMENTAL MARKET SIZE ESTIMATION

(TOP-DOWN APPROACH)            59

FIGURE 11            BIOBANKING MARKET: CAGR PROJECTIONS (2025–2030)          60

FIGURE 12            BIOBANKING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS       62

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 63

FIGURE 14            BIOBANKING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)       66

FIGURE 15            BIOBANKING SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)                67

FIGURE 16            BIOBANKING PRODUCTS MARKET, BY WORKFLOW, 2025 VS. 2030 (USD MILLION)           67

FIGURE 17            BIOBANKING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)                68

FIGURE 18            BIOBANKING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)         68

FIGURE 19            BIOBANKING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      69

FIGURE 20            REGIONAL SNAPSHOT OF BIOBANKING MARKET               69

FIGURE 21            GROWTH IN PRECISION MEDICINE AND CELL & GENE THERAPY

R&D TO DRIVE MARKET                72

FIGURE 22            US AND PRODUCTS COMMANDED LARGEST MARKET SHARE IN

NORTH AMERICAN BIOBANKING MARKET IN 2024           73

FIGURE 23            BIOBANKS DOMINATED BIOBAKING PRODUCTS MARKET, BY END USER, IN 2024         73

FIGURE 24            PHARMA-BIOTECH COMPANIES & CROS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024                 74

FIGURE 25            CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 74

FIGURE 26            BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          75

FIGURE 27            REVENUE SHIFT & NEW REVENUE POCKETS FOR BIOBANKING PRODUCT & SERVICE PROVIDERS      81

FIGURE 28            BIOBANKING MARKET: VALUE CHAIN ANALYSIS                 84

FIGURE 29            BIOBANKING MARKET: ECOSYSTEM ANALYSIS                 86

FIGURE 30            TOP PATENT APPLICATIONS/OWNERS AND NUMBER OF PATENTS GRANTED IN BIOBANKING MARKET, JANUARY 2014–DECEMBER 2024 89

FIGURE 31            BIOBANKING MARKET: PORTER’S FIVE FORCES ANALYSIS            98

FIGURE 32            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING              100

FIGURE 33            KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS, BY END USER            101

FIGURE 34            KEY BUYING CRITERIA FOR BIOBANKING SERVICES, BY END USER                102

FIGURE 35            BIOBANKING MARKET: FUNDING AND NUMBER OF M&A DEALS,

2020−2024 (USD BILLION)           104

FIGURE 36            PE/VC INVESTMENTS IN THE PHARMACEUTICAL SECTOR (2024)          105

FIGURE 37            IMPACT OF AI/GEN AI ON BIOBANKING MARKET ECOSYSTEM    106

FIGURE 38            NORTH AMERICA: BIOBANKING MARKET SNAPSHOT          248

FIGURE 39            ASIA PACIFIC: BIOBANKING MARKET SNAPSHOT          295

FIGURE 40            REVENUE ANALYSIS OF KEY PLAYERS IN BIOBANKING PRODUCTS MARKET,

2020–2024 (USD MILLION)            385

FIGURE 41            REVENUE ANALYSIS OF KEY PLAYERS IN BIOBANKING SERVICES &

SOFTWARE MARKET, 2020–2024 (USD MILLION)                 386

FIGURE 42            MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOBANKING

PRODUCTS MARKET (2024)         387

FIGURE 43            MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOBANKING SERVICES & SOFTWARE MARKET (2024)     389

FIGURE 44            BIOBANKING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         392

FIGURE 45            BIOBANKING MARKET: COMPANY FOOTPRINT                 393

FIGURE 46            BIOBANKING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 398

FIGURE 47            EV/EBITDA OF KEY PLAYERS      401

FIGURE 48            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY PLAYERS  401

FIGURE 49            EV/EBITDA OF KEY PLAYERS      402

FIGURE 50            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY PLAYERS  402

FIGURE 51            BRAND/PRODUCT COMPARATIVE ANALYSIS OF BIOBANKING PRODUCTS             403

FIGURE 52            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT          408

FIGURE 53            PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT          418

FIGURE 54            BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT   423

FIGURE 55            QIAGEN: COMPANY SNAPSHOT                 428

FIGURE 56            MERCK KGAA: COMPANY SNAPSHOT     434

FIGURE 57            AVANTOR, INC.: COMPANY SNAPSHOT 438

FIGURE 58            CRYOPORT: COMPANY SNAPSHOT          444

FIGURE 59            TECAN TRADING AG: COMPANY SNAPSHOT                 450

FIGURE 60            AZENTA US INC.: COMPANY SNAPSHOT                 454

FIGURE 61            GREINER AG: COMPANY SNAPSHOT       458

FIGURE 62            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT          462

FIGURE 63            LABCORP: COMPANY SNAPSHOT             464

FIGURE 64            EUROFINS SCIENTIFIC: COMPANY SNAPSHOT                 467

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧